3N1Q.D | CDON

General Structure Information 3n1q CDON crystal structure of dhhn bound to cdofn3 2.89Å AUTH J.M.KAVRAN,M.D.WARD,O.O.OLADOSU,S.MULEPATI,D.J.LEAHYTITL ALL MAMMALIAN HEDGEHOG PROTEINS INTERACT WITH CDO AND BOCTITL 2 IN A CONSERVED MANNER.REF J.BIOL.CHEM. 2010REFN ESSN 1083-351XPMID 20519495DOI 10.1074/JBC.M110.131680 Variant Set Distributions Mapped Variants

See Details
2CR6.A | OBSCN

General Structure Information 2cr6 OBSCN solution structure of the ig domain (2998-3100) of human obscurin -1.0Å AUTH K.NAGASHIMA,F.HAYASHI,M.YOSHIDA,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE IG DOMAIN (2998-3100) OFTITL 2 HUMAN OBSCURINREF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
3KGR.B | LAIR1

General Structure Information 3kgr LAIR1 crystal structure of the human leukocyte-associated ig-like receptor-1 (lair-1) 1.8Å AUTH T.H.C.BRONDIJK,T.DE RUITER,J.BALLERING,H.WIENK,R.J.LEBBINK,AUTH 2 H.VAN INGEN,R.BOELENS,R.W.FARNDALE,L.MEYAARD,E.G.HUIZINGATITL CRYSTAL STRUCTURE AND COLLAGEN-BINDING SITE OF IMMUNETITL 2 INHIBITORY RECEPTOR LAIR-1: UNEXPECTED IMPLICATIONS FORTITL 3 COLLAGEN BINDING BY PLATELET RECEPTOR GPVIREF BLOOD V. 115 1364 2010REFN ISSN 0006-4971PMID 20007810DOI 10.1182/BLOOD-2009-10-246322 Variant Set Distributions Ripley’s […]

See Details
4LP5.A | AGER

General Structure Information 4lp5 AGER crystal structure of the full-length human rage extracellular domain (vc1c2 fragment) 3.8Å AUTH L.YATIME,G.R.ANDERSENTITL STRUCTURAL INSIGHTS INTO THE OLIGOMERIZATION MODE OF THETITL 2 HUMAN RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS.REF FEBS J. V. 280 6556 2013REFN ISSN 1742-464XPMID 24119142DOI 10.1111/FEBS.12556 Variant Set Distributions Mapped Variants

See Details
1GXE.A | MYBPC3

General Structure Information 1gxe MYBPC3 central domain of cardiac myosin binding protein c -1.0Å AUTH S.IDOWU,M.GAUTEL,S.PERKINS,M.PFUHLTITL STRUCTURE, STABILITY AND DYNAMICS OF THE CENTRALTITL 2 DOMAIN OF CARDIAC MYOSIN BINDING PROTEIN CTITL 3 (MYBP-C): IMPLICATIONS FOR MULTIDOMAIN ASSEMBLYTITL 4 AND CAUSES FOR CARDIOMYOPATHYREF J.MOL.BIOL. V. 329 745 2003REFN ISSN 0022-2836PMID 12787675DOI 10.1016/S0022-2836(03)00425-X Variant Set Distributions Ripley’s […]

See Details
1V05.A | FLNC

General Structure Information 1v05 FLNC dimerization of human filamin c: crystal structure of the domain 24 1.43Å AUTH R.PUDAS,T.-R.KIEMA,P.J.G.BUTLER,M.STEWART,J.YLANNETITL STRUCTURAL BASIS FOR VERTEBRATE FILAMINTITL 2 DIMERIZATIONREF STRUCTURE V. 13 111 2005REFN ISSN 0969-2126PMID 15642266DOI 10.1016/J.STR.2004.10.014 Variant Set Distributions Mapped Variants

See Details
2K1M.A | MYBPC3

General Structure Information 2k1m MYBPC3 3d nmr structure of domain cc0 of cardiac myosin binding protein c (mybpc) -1.0Å AUTH J.RATTI,M.GAUTEL,M.PFUHLTITL 3D NMR STRUCTURE OF DOMAIN CC0 OF CARDIAC MYOSINTITL 2 BINDING PROTEIN C (MYBPC)REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
3N1P.B | IHH

General Structure Information 3n1p IHH crystal structure of ihhn bound to bocfn3 2.7Å AUTH J.M.KAVRAN,M.D.WARD,O.O.OLADOSU,S.MULEPATI,D.J.LEAHYTITL ALL MAMMALIAN HEDGEHOG PROTEINS INTERACT WITH CDO AND BOCTITL 2 IN A CONSERVED MANNER.REF J.BIOL.CHEM. 2010REFN ESSN 1083-351XPMID 20519495DOI 10.1074/JBC.M110.131680 Variant Set Distributions Pathogenic Proximity Analysis Mapped Variants

See Details
3N1P.B | IHH

General Structure Information 3n1p IHH crystal structure of ihhn bound to bocfn3 2.7Å AUTH J.M.KAVRAN,M.D.WARD,O.O.OLADOSU,S.MULEPATI,D.J.LEAHYTITL ALL MAMMALIAN HEDGEHOG PROTEINS INTERACT WITH CDO AND BOCTITL 2 IN A CONSERVED MANNER.REF J.BIOL.CHEM. 2010REFN ESSN 1083-351XPMID 20519495DOI 10.1074/JBC.M110.131680 Variant Set Distributions Pathogenic Proximity Analysis Mapped Variants

See Details
3N1P.B | IHH

General Structure Information 3n1p IHH crystal structure of ihhn bound to bocfn3 2.7Å AUTH J.M.KAVRAN,M.D.WARD,O.O.OLADOSU,S.MULEPATI,D.J.LEAHYTITL ALL MAMMALIAN HEDGEHOG PROTEINS INTERACT WITH CDO AND BOCTITL 2 IN A CONSERVED MANNER.REF J.BIOL.CHEM. 2010REFN ESSN 1083-351XPMID 20519495DOI 10.1074/JBC.M110.131680 Variant Set Distributions Pathogenic Proximity Analysis Mapped Variants

See Details